Entrada Therapeutics, Inc.
TRDA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001689375
In the last 90 days, Entrada Therapeutics, Inc. insiders filed 0 open-market purchases and 7 sales; 128 institutions reported holding it in 13F filings for Q2 2026, worth $214.4M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Entrada Therapeutics, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 55 | 62 | +7 |
| Shares | 26.0M | 26.3M | +246.3K (+0.9%) |
| Value | $411.4M | $396.6M | −$14.7M (−3.6%) |
New holders (10)
Institutions that held Entrada Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Advantage Alpha Capital Partners LP | 105,137 | $1.59M | 0.30% |
| Millennium Management LLC | 23,967 | $361.7K | 0.00% |
| Invesco Ltd. | 17,296 | $261.0K | 0.00% |
| Franklin Resources Inc | 13,206 | $199.3K | 0.00% |
| Oracle Alpha Inc. | 12,500 | $188.6K | 0.24% |
| State of Wyoming | 5,932 | $89.5K | 0.02% |
| Lazard Asset Management LLC | 2,668 | $40.0K | 0.00% |
| Plato Investment Management Ltd | 1,116 | $16.8K | 0.02% |
| Federated Hermes, Inc. | 908 | $13.7K | 0.00% |
| Nisa Investment Advisors, LLC | 10 | $151 | 0.00% |
Sold out (3)
Institutions that held Entrada Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Cornercap Investment Counsel Inc | 13,977 | $220.8K |
| State of Wisconsin Investment Board | 10,023 | $158.4K |
| Advisor Group Holdings, Inc. | 300 | $4.74K |